Suchen
Standard BioTools Inc
LABZur Watchlist hinzufügen
0.913USD
+0.046+5.32%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
356.16MMarktkapitalisierung
4.57KGV TTM
mehr Informationen über Standard BioTools Inc Unternehmen
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
Standard BioTools Inc Informationen
BörsenkürzelLAB
Name des UnternehmensStandard BioTools Inc
IPO-datumFeb 10, 2011
CEOEgholm (Michael)
Anzahl der mitarbeiter818
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 10
Addresse2 Tower Place
StadtSOUTH SAN FRANCISCO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94080
Telefon16502666000
Websitehttps://www.standardbio.com/
BörsenkürzelLAB
IPO-datumFeb 10, 2011
CEOEgholm (Michael)
Führungskräfte von Standard BioTools Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
222.69K
+44.51%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
222.69K
+44.51%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Standard BioTools Inc?
Die fünf größten Anteilseigner von Standard BioTools Inc sind: Mr. Sean Mackay
Wie viele Institutionen halten Anteile an Standard BioTools Inc (LAB)?
Mit Stand vom 2026Q1 halten 342 Institutionen Anteile an Standard BioTools Inc, mit einem Gesamtmarktwert von etwa 317.36M, was 81.30% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 773508.00 gestiegen.
Was ist die größte Einnahmequelle von Standard BioTools Inc?
Am 2026Q1 erzielte das Geschäft mit Consumables für Standard BioTools Inc den höchsten Umsatz in Höhe von 36.25M, was 42.48% des Gesamtumsatzes entspricht.